At the news
? NEUTRALIMPACT 3/10 8-K filed Mar 12, 2026 at 07:21 ET
Analysis based on filing metadata only, document content was unavailable. The filing is an 8-K with Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits), suggesting Dianthus Therapeutics may have entered a significant agreement, but no details are accessible to confirm nature or terms.
- Filing is Form 8-K with Items 1.01 and 9.01 reported.
- Item 1.01 indicates a material definitive agreement may have been entered into.
- Item 9.01 suggests financial statements or exhibits were filed, possibly related to the agreement.
- No document content available to verify agreement type, parties, or financial terms.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access